Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice

INTRODUCTION: The EDITION development program confirmed that insulin glargine 300 U/mL (Gla-300) provides comparable glycemic control to insulin glargine 100 U/mL (Gla-100) but with lower hypoglycemia risk. Our study aimed to evaluate the effectiveness of Gla-300 in everyday practice. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidvégi, Tibor, Balogh, Zoltán, Vass, Viktor, Kovács, Gábor, Stella, Péter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995788/
https://www.ncbi.nlm.nih.gov/pubmed/31901115
http://dx.doi.org/10.1007/s13300-019-00746-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995788/
https://www.ncbi.nlm.nih.gov/pubmed/31901115
http://dx.doi.org/10.1007/s13300-019-00746-4

Ejemplares similares